SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

KMS Medisurgi board to adopt audited financial results

22 Jun 2021 Evaluate

KMS Medisurgi has informed that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021, to adopt Audited Financial Results for the quarter and financial year ended 31st March 2021; to adopt and approve the Balance Sheet for the year ended 31st March, 2021 together with Profit and Loss Account and Cashflow statement as on that date and Report of the Auditors thereon; and to consider other business, if any.

The above information is a part of company’s filings submitted to BSE.

KMS Medisurgi Share Price

126.50 0.00 (0.00%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 547.10
Poly Medicure 1462.20
Laxmi Denta 189.20
Nureca Ltd. 260.95
Hemant Surgical Inds 295.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×